Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021

Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021

A SARS-CoV-2 P.1 (Gamma) variant outbreak occurred at a skilled nursing facility in Washington, USA, in April 2021. Effectiveness of 2 doses of mRNA vaccines against P.1 infection among residents in this outbreak was 75.0% (95% CI 44.5%–88.7%), similar to effectiveness for other pre-Delta variants...

Full description

Bibliographic Details
Main Authors: James W. Lewis, Julie Loughran, Li Deng, Jasmine Varghese, Shauna Clark, Casandra Harrison, Molly Gacetta, John A. Jernigan, Katherine E. Fleming-Dutra
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2022-11-01
Series:Emerging Infectious Diseases
Subjects:
COVID-19
SARS-CoV-2
P.1
vaccine effectiveness
long-term care
respiratory infections
Online Access:https://wwwnc.cdc.gov/eid/article/28/11/22-1043_article

Internet

https://wwwnc.cdc.gov/eid/article/28/11/22-1043_article

Similar Items